Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
Lancet. 2022 Dec 3;400(10367):1927-1937. doi: 10.1016/S0140-6736(22)02034-7. Epub 2022 Nov 7.
Lancet. 2022.
PMID: 36356632
Clinical Trial.
Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients.
Hubacek JA, Bloudícková S, Bohuslavová R, Táborský P, Polakovic V, Sazamová M, Svítilová E, Vlasák J, Sojková I, Ryba M, Knetl P, Ullrych M, Drahozal R, Pavuková V, Pavlíková B, Fischlová D, Mokrejsová M, Chmelícková H, Pauchová E, Vyskocil P, Nýdlová Z, Kopenec J, Fixa P, Hajný J, Bubenícek P, Syrovátka P, Zahálková J, Surel S, Hobzek Z, Hrubý A, Suchanová J, Vanková S, Brabcová J, Viklický O; MIA Group.
Hubacek JA, et al. Among authors: ullrych m.
Clin Chem Lab Med. 2007;45(9):1121-3. doi: 10.1515/CCLM.2007.141.
Clin Chem Lab Med. 2007.
PMID: 17635077
Item in Clipboard
Cite
Cite